1117-AB78 202204 Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Audio-Only Telemedicine for Buprenorphine Initiation for Treatment of Opioid Use Disorder

DEA is promulgating regulatory changes which would clarify the rights and obligations for DATA-waived registrants when prescribing buprenorphine to patients with Opioid Use Disorder pursuant to a telemedicine encounter which utilizes audio-only telecommunication systems.

]]> Other Significant First Time Published in The Unified Agenda Proposed Rule Stage Undetermined No 21 CFR 1300 21 CFR 1304 21 CFR 1306 21 U.S.C. 802(54)(G) No NPRM 08/00/2022 Undetermined Undetermined Undetermined Undetermined www.regulations.gov No No Scott Brinks A. Section Chief, Regulatory Drafting and Support Section, Diversion Control Division 1117 Drug Enforcement Administration DEA 571 362-8209 scott.a.brinks@dea.gov 8701 Morrissette Drive, Springfield VA 22152